Literature DB >> 7686709

Effect of methylprednisolone on the cytokine response in patients undergoing lung surgery.

E Tønnesen1, M Wanscher, K Höhndorf, K Bendtzen, M B Hansen, M Diamant, G L Hansen, P Toft.   

Abstract

Tumour necrosis factor alpha (TNF alpha), interleukin-1 alpha (IL-1 alpha) and IL-6, when released in excess, have been suggested to be important host mediators of the immunoinflammatory response to injury and infections. Corticosteroids suppress this response in vitro. This study was undertaken to investigate if a single dose of methylprednisolone (MP) could modify the cytokine response in patients undergoing lung surgery. Twenty-one patients with lung cancer were allocated randomly to treatment with MP 30 mg/kg i.v. (MP group) or isotonic saline (control group). Patients were anaesthetized with a balanced anaesthesia combined with thoracic epidural anaesthesia. MP or saline was administered immediately before induction of anaesthesia. The cytokines in plasma were measured by ELISA, and blood samples were collected preoperatively, at the end of surgery, 4 h later, and 1 and 5 days postoperatively. All patients had detectable IL-6 in plasma. Compared to preoperative values, plasma IL-6 levels in the MP group increased from 114 pg/ml (12-350 pg/ml) (mean, range) to peak value 146 pg/ml (15-580 pg/ml) on the first postoperative day. In the control group, IL-6 levels increased from 99 pg/ml (17-350 pg/ml) preoperatively to 125 pg/ml (10-300 pg/ml) on the first postoperative day. The increases were not significant. TNF alpha was detectable in only two patients, one from each group. Low levels of IL-1 alpha were demonstrated in three patients in the MP group and in four patients in the control group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686709     DOI: 10.1111/j.1399-6576.1993.tb03738.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

1.  Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review.

Authors:  S Sauerland; M Nagelschmidt; P Mallmann; E A Neugebauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

2.  Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Xi Fu; Xin Ye; Jing Dong; Yi-Feng Ren; Li-Na An; Hua Jiang; Wen-Bo Huang; Ya Huang
Journal:  Pain Ther       Date:  2022-10-19

3.  Determination of urinary trypsin inhibitor provides insight into postoperative complications in patients following esophagectomy.

Authors:  Ichiro Akagi; Masao Miyashita; Ken Takahashi; Takeshi Matsutani; Akihisa Matsuda; Tsutomu Nomura; Hiroshi Makino; Nobutoshi Hagiwara; Eiji Uchida
Journal:  Exp Ther Med       Date:  2012-04-18       Impact factor: 2.447

4.  Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopy.

Authors:  Helene Benveniste; Shaonan Zhang; Ruth A Reinsel; Haifang Li; Hedok Lee; Mario Rebecchi; William Moore; Christoffer Johansen; Douglas L Rothman; Thomas V Bilfinger
Journal:  Int J Clin Exp Med       Date:  2012-04-06

5.  Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial-the 'DEXAPAE' study.

Authors:  Petra Svarc; Hein Vincent Stroomberg; Ruben Juhl Jensen; Susanne Frevert; Mats Håkan Lindh; Mikkel Taudorf; Klaus Brasso; Lars Lönn; Martin Andreas Røder
Journal:  BMJ Open       Date:  2021-11-01       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.